Health Care & Life Sciences » Pharmaceuticals | Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
11,862.00
10,699.00
2,787.00
10,532.00
4,508.00
6,660
Depreciation, Depletion & Amortization
13,078.00
14,448.00
13,252.00
14,564.00
15,436.00
16,516
Other Funds
647.00
1,109.00
107.00
-
-
17,645
Funds from Operations
34,273.00
5,433.00
15,819.00
38,191.00
38,627.00
26,087
Changes in Working Capital
3,231.00
15,619.00
5,138.00
369.00
582.00
12,104
Net Operating Cash Flow
31,042.00
21,052.00
10,681.00
38,560.00
39,209.00
38,191
Capital Expenditures
18,302.00
20,499.00
16,047.00
21,382.00
35,099.00
Sale of Fixed Assets & Businesses
-
-
51.00
-
-
Purchase/Sale of Investments
513.00
-
-
527.00
1,995.00
Net Investing Cash Flow
18,298.00
39,773.00
17,135.00
39,396.00
35,990.00
Issuance/Reduction of Debt, Net
8,579.00
2,709.00
2,206.00
4,454.00
9,271.00
Net Financing Cash Flow
9,370.00
32,117.00
2,237.00
7,140.00
7,718.00
Net Change in Cash
3,374.00
14,241.00
1,964.00
6,385.00
3,995.00
Free Cash Flow
13,400.00
2,381.00
5,366.00
17,178.00
4,110.00
Deferred Taxes & Investment Tax Credit
2,248.00
8,743.00
7,880.00
3,618.00
3,899.00
1,414
Net Assets from Acquisitions
-
18,352.00
-
12,461.00
-
Other Sources
50.00
-
-
-
2,000.00
Change in Capital Stock
144.00
35,935.00
4,336.00
11,594.00
16,989.00
Exchange Rate Effect
-
845.00
2,253.00
81.00
504.00
Other Uses
559.00
922.00
1,139.00
5,026.00
896.00

About Amphastar Pharmaceuticals

View Profile
Address
11570 6th Street
Rancho Cucamonga California 91730
United States
Employees -
Website http://www.amphastar.com
Updated 07/08/2019
Amphastar Pharmaceuticals, Inc. engages in the development, manufacture, market, and sale of technically challenging and proprietary injectable, inhalation, and intranasal products. It operates through Finished Pharmaceutical Products, and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets and distributes enoxaparin, cortrosyn, amphadase, naloxone, lidocaine jelly, as well as various other critical and non-critical care drugs.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.